Custom Search
Salmeterol News
Study fuels debate over beta agonists such as Serevent and Advair
Adding to the ongoing controversy over a popular class of asthma inhaler medications, a new data review suggests the drugs may be dangerous.
Learning Objectives for This Educational Activity
Upon completion of this activity, participants will be able to:
GSK Announces New Product Labels For SereventŪ And AdvairŪ
GlaxoSmithKline today announced that it has agreed with the U.S. Food and Drug Administration on product labeling for its respiratory products SereventŪ DiskusŪ and Advair DiskusŪ.
Patients Satisfied With Fluticasone/Salmeterol Treatment by Diskus for COPD: Presented at CHEST
Patients reported a high degree of satisfaction after 2 months of using a new treatment for chronic obstructive pulmonary disease (COPD).
Displaying results 11 to 14 out of 14